Real-World Strategies to Treat Hypertension Associated with Pediatric Obesity

  • Edem BinkaEmail author
  • Tammy M. Brady
Hypertension and Metabolic Syndrome (John Sperati, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Hypertension and Metabolic Syndrome


Purpose of Review

To review the most recent literature on current strategies for the treatment of hypertension associated with pediatric obesity.

Recent Findings

Over the last three decades, childhood and adolescent overweight and obesity prevalence in the USA has continued to rise. Unsurprisingly but rather disturbingly, this rising prevalence has been paralleled by an increase in cardiovascular disease (CVD) risk factors in childhood such as hypertension, dyslipidemia, and diabetes that become manifest earlier than previously reported. These childhood CVD risk factors are not only associated with target organ damage in childhood but also track into adulthood, increasing the risk of long-term CVD morbidity and mortality.


There have been several mechanisms proposed to explain the role of obesity on the development of hypertension in childhood. However, central to the management of obesity-related hypertension is a multifaceted approach targeting lifestyle modifications and weight loss. Effective treatment often also requires a pharmacologic approach and rarely bariatric surgery.


Obesity Adiposity Blood pressure Hypertension Cardiovascular disease risk factors Weight management Lifestyle modifications Pharmacotherapy 


Compliance with Ethics Guidelines

Conflict of Interest

Dr. Brady reports grants from NIH/NHLBI, grants from NIH/NIMH, grants from AHRQ, and grants from RESOLVE to Save Lives, during the conduct of the study. Dr. Binka reports grants from NIH/NHLBI during the conduct of the study.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Turer CB, Brady TM, De Ferranti SD. Obesity, hypertension, and dyslipidemia in childhood are key modifiable antecedents of adult cardiovascular disease: a call to action. Circulation. 2018;137(12):1256–9. Scholar
  2. 2.
    Brady TM. Obesity-related hypertension in children. Front Pediatr. 2017;5:1–7. Scholar
  3. 3.
    Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.
  4. 4.
    Fixler DE, Laird WP, Fitzgerald V, Stead S, Adams R. Hypertension screening in schools: results of the Dallas study. Pediatrics. 1979 Jan;63(1):32-6.
  5. 5.
    Sinaiko AR, Gomez-Marin O, Prineas RJ. Prevalence of “significant” hypertension in junior high school-aged children: The Children and Adolescent Blood Pressure Program. J Pediatr. 1989;114(4 PART 1):664–9. Scholar
  6. 6.
    •• Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. A comprehensive guideline statement with current recommendation s for the screening and management of high blood pressure in children and adolescent, with important differences from the previous pediatric guidelines. This document has many useful tables and figures to facilitate implementation of the guidelines into clinical practice, and includes links to several online resources.
  7. 7.
    • Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton lipid research clinics follow-up study. Pediatrics. 2007;120(2):340–5. Twenty-five year longitudinal follow up study that demonstrated childhood metabolic syndrome increases the risk of cardiovascular disease in adulthood 8. Association between adiposity and left ventricular mass in children with hypertension CrossRefPubMedGoogle Scholar
  8. 8.
    • Brady TM, Appel LJ, Holmes KW, Fivush B, Miller ER. Association between adiposity and left ventricular mass in children with hypertension. J Clin Hypertens. 2016;18(7):625–33. One-year prospective observational study which demonstrated a strong independent association between adiposity and LVH. Specifically, children with persistent overweight/obesity had a greater LVMI increase than children who remained at a healthy weight over the course of the study and baseline body mass index z-score independently predicted the change in LVMI.
  9. 9.
    Wade K, Chiesa ST, Hughes AD, et al. Assessing the causal role of BMI on cardiovascular health in young adults. Circulation. 2018;138:2187–201. Scholar
  10. 10.
    Köchli S, Endes K, Steiner R, et al. Determine vascular phenotype in young children the EXAMIN YOUTH study. 2018;1–9. doi:
  11. 11.
    Kumar S, Kelly AS. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clin Proc. 2017;92(2):251–65. Scholar
  12. 12.
    Li L, Pérez A, Wu L-T, Ranjit N, Brown HS, Kelder SH. Cardiometabolic risk factors among severely obese children and adolescents in the United States, 1999–2012. Child Obes. 2016;12(1):12–9. Scholar
  13. 13.
    Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40:947–63.
  14. 14.
    Kidambi S, Kotchen TA. Treatment of hypertension in obese patients. Am J Cardiovasc Drugs. 2013;13(3):163–75. Scholar
  15. 15.
    Vecchiola A, Lagos CF, Carvajal CA, Baudrand R, Fardella CE. Aldosterone production and signaling dysregulation in obesity. Curr Hypertens Rep. 2016;18(3):1–9. Scholar
  16. 16.
    • Schütten MTJ, Houben AJHM, de Leeuw PW, Stehouwer CDA. The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology. 2017;32(3):197–209. Comprehensive review paper on the association of the renin-angiotensinaldosterone system (RAAS) with obesity-related hypertension.CrossRefPubMedGoogle Scholar
  17. 17.
    Mameli C, Zuccotti GV, Carnovale C, Galli E, Nannini P, Cervia D, et al. An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. Pharmacol Res. 2017;119:99–117.
  18. 18.
    Muhamed PK, Olsen MH, Holm JC, Ibsen H, Hvidt KN. Cuff size influences blood pressure measurement in obese children and adolescents. Dan Med J. 2016;63(1):A5183.PubMedGoogle Scholar
  19. 19.
    Mourad JJ, Lopez-Sublet M, Aoun-Bahous S, Villeneuve F, Jaboureck O, Dourmap-Collas C, et al. Impact of miscuffing during home blood pressure measurement on the prevalence of masked hypertension. Am J Hypertens. 2013;26(10):1205–9.
  20. 20.
    Ostchega Y, Zhang G, Kit BK, Nwankwo T. Factors associated with home blood pressure monitoring among US adults: National Health and Nutrition Examination Survey, 2011–2014. Am J Hypertens. 2017;30(11):1026–32. Scholar
  21. 21.
    Palatini P, Benetti E, Fania C, Malipiero G, Saladini F. Rectangular cuffs may overestimate blood pressure in individuals with large conical arms. J Hypertens. 2012;30(3):530–6. Scholar
  22. 22.
    • The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–576. Accessed August 19, 2014. Previous guideline statement on the screening and management of high blood pressure in children and adolescents.
  23. 23.
    Medrano L, Amatya K, Vizthum D, Fadrowski JJ, Brady TM. Association of mood disorders with cardiovascular disease risk factors in overweight and obese youth with elevated blood pressure. J Clin Hypertens. 2018;20(9):1268–75. Scholar
  24. 24.
    •• Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Supplement):S164–92. Summary report by an expert committee, consisting of a multidisciplinary group with representation across medicine, nutrition, nursing, psyc hology, and epidemiology, on guidelines for assessment and treatment of overweight and obesity among children and adolescents.CrossRefPubMedGoogle Scholar
  25. 25.
    • Paula Bricarello L, Poltronieri F, Fernandes R, Retondario A, de Moraes Trindade EBS, de Vasconcelos FAG. Effects of the dietary approach to stop hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: a systematic review. Clin Nutr ESPEN. 2018;28:1–11. An important systematic review of published literature through March 2018 describing the likely beneficial effects of the DASH diet on blood pressure, overweight and obesity in adolescents. This review included results from cross-sectional studies, cohort studies and randomized clinical trials.CrossRefPubMedGoogle Scholar
  26. 26.
    • Saneei P, Salehi-Abargouei A, Esmaillzadeh A, Azadbakht L. Influence of dietary approaches to stop hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials. Nutr Metab Cardiovasc Dis. 2014;24(12):1253–61. Scholar
  27. 27.
    Yang Q, Zhang Z, Kuklina EV, Fang J, Ayala C, Hong Y, et al. Sodium intake and blood pressure among US children and adolescents. Pediatrics. 2012;130(4):611–9.
  28. 28.
    •• US Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: US Department of Health and Human Services; 2018. Essential resource from the Department of Health and Human Services with comprehensive physical activity guidelines to promote health.Google Scholar
  29. 29.
    Poitras VJ, Gray CE, Borghese MM, et al. Systematic review of the relationships between objectively measured physical activity and health indicators in school-aged children and youth 1. Appl Physiol Nutr Metab. 2016;41(6 (Suppl. 3)):S197–239. Scholar
  30. 30.
    Taylor SJA, Rennie K, Jon C. Clinical outcomes of an inpatient pediatric obesity treatment program in the USA. Int J Adolesc Med Health. 2017.
  31. 31.
    Turner T, Spruijt-Metz D, Wen CKF, Hingle MD. Prevention and treatment of pediatric obesity using mobile and wireless technologies: a systematic review. Pediatr Obes. 2015;10(6):403–9. Scholar
  32. 32.
    Ashrafian H, Toma T, Harling L, Kerr K, Athanasiou T, Darzi A. Social networking strategies that aim to reduce obesity have achieved significant although modest results. Health Aff. 2014;33(9):1641–7. Scholar
  33. 33.
    Rivera J, McPherson AC, Hamilton J, et al. User-centered design of a mobile app for weight and health management in adolescents with complex health needs: qualitative study. J Med Internet Res. 2018;20(4):1–15. Scholar
  34. 34.
    Weinberger MH, Roniker B, Krause SL, Weiss RJ. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens. 2002;15(8):709–16. Scholar
  35. 35.
    Chapman N, Dobson J, Wilson S, Dahlöf B, Sever PS, Wedel H, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49(4):839–45.
  36. 36.
    Václavík J, Sedlák R, Plachý M, Navrátil K, Plášek J, Jarkovský J, et al. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Hypertension. 2011;57(6):1069–75.
  37. 37.
    Václavík J, Sedlák R, JarkovskÝ J, Kociánová E, TáborskÝ M. Effect of spironolactone in resistant arterial hypertension. Med (United States). 2014;93(27):1–9. Scholar
  38. 38.
    Calhoun DA, White WB. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. J Am Soc Hypertens. 2008;2(6):462–8. Scholar
  39. 39.
    •• Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709–57. A guideline statement from the European Society of Endocrinology and the Pediatric Endocrine society on the assessment, treatment and prevention of pediatric obesity.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    •• Grossman DC, Bibbins-Domingo K, Curry SJ, et al. Screening for obesity in children and adolescents us preventive services task force recommendation statement. JAMA. 2017;317(23):2417–26. Statement from the US Preventive Services Task Force with guidelines for screening for obesity in children and adolescents.CrossRefPubMedGoogle Scholar
  41. 41.
    Inge TH, Coley RY, Bazzano LA, Xanthakos SA, McTigue K, Arterburn D, et al. Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study. Surg Obes Relat Dis. 2018;14(9):1374–86.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Pediatric CardiologyJohns Hopkins University, Bloomberg Children’s CenterBaltimoreUSA
  2. 2.Division of Pediatric NephrologyJohns Hopkins UniversityBaltimoreUSA

Personalised recommendations